CARF (CDKN2AIP) Regulates Hepatic Lipid Metabolism and Protects Against Development of Non-Alcoholic Fatty Liver Diseases

Non-alcoholic fatty liver diseases (NAFLD) is the most common form of liver diseases in the USA with 30–40% of American being affected and about 12% with nonalcoholic steatohepatitis (NASH), a leading cause of end-stage liver diseases. NAFLD has been linked with insulin resistance, type2 diabetes, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasan, Kamrul M, Parveen, Meher, Pena, Alondra, Calles, Erick Galdamez, Gergis, Marvy, Espinoza-Derout, Jorge, Sinha-Hikim, Amiya, Friedman, Theodore C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Cardiovascular Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089945/
http://dx.doi.org/10.1210/jendso/bvab048.577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089945/
http://dx.doi.org/10.1210/jendso/bvab048.577

Ejemplares similares